Collapse and Restoration of Hair Follicle Immune Privilege Ex Vivo: A Model for Alopecia Areata.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 22 4 2020
pubmed: 22 4 2020
medline: 16 3 2021
Statut: ppublish

Résumé

Alopecia areata (AA) is a hair follicle (HF) autoimmune disease leading to hair loss. Interferon gamma (IFNγ) is regarded as the key cytokine involved in AA development, which has been shown to play a role in the collapse of HF immune privilege (IP), CD8

Identifiants

pubmed: 32314213
doi: 10.1007/978-1-0716-0648-3_11
doi:

Substances chimiques

Biomarkers 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-141

Références

Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366:1515–1525
doi: 10.1056/NEJMra1103442
McElwee KJ, Gilhar A, Tobin DJ et al (2013) What causes alopecia areata? Exp Dermatol 22:609–626
doi: 10.1111/exd.12209
Darwin E, Hirt PA, Fertig R et al (2018) Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology 10:51–60
doi: 10.4103/ijt.ijt_99_17
Freyschmidt-Paul P, Zoller M, McElwee KJ et al (2005) The functional relevance of the type 1 cytokines IFN-gamma and IL-2 in alopecia areata of C3H/HeJ mice. J Investig Dermatol Symp Proc 10:282–283
doi: 10.1111/j.0022-202X.2005.10130_5.x
Freyschmidt-Paul P, McElwee KJ, Hoffmann R et al (2006) Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 155:515–521
doi: 10.1111/j.1365-2133.2006.07377.x
Ito T, Ito N, Bettermann A et al (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164:623–634
doi: 10.1016/S0002-9440(10)63151-3
Ito T, Ito N, Saathoff M et al (2005) Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol 152:623–631
doi: 10.1111/j.1365-2133.2005.06453.x
Paus R, Bulfone-Paus S, Bertolini M (2018) Hair follicle immune privilege revisited: the key to alopecia areata management. J Investig Dermatol Symp Proc 19:S12–S17
doi: 10.1016/j.jisp.2017.10.014
Meyer KC, Bodó E, Brzoska T et al (2009) Immunomodulatory effects of the alpha-melanocyte-stimulating hormone-related tripeptide K(D)PT on human scalp hair follicles under proinflammatory conditions. Br J Dermatol 161:1400–1403
doi: 10.1111/j.1365-2133.2009.09427.x
Kinori M, Bertolini M, Funk W et al (2012) Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-γ-induced collapse of human hair follicle immune privilege. Exp Dermatol 21:223–226
doi: 10.1111/j.1600-0625.2011.01432.x
Bertolini M, Pretzlaff M, Sulk M et al (2016) Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse. Br J Dermatol 175:531–541
doi: 10.1111/bjd.14645
Langan EA, Philpott MP, Kloepper JE et al (2015) Human hair follicle organ culture: theory, application and perspectives. Exp Dermatol 24:903–911
doi: 10.1111/exd.12836
Philpott MP, Green MR, Kealey T (1990) Human hair growth in vitro. J Cell Sci 97(Pt 3):463–471
doi: 10.1242/jcs.97.3.463
Kloepper JE, Sugawara K, Al-Nuaimi Y et al (2010) Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture. Exp Dermatol 19:305–312
doi: 10.1111/j.1600-0625.2009.00939.x

Auteurs

Markus Fehrholz (M)

Monasterium Laboratory, Skin and Hair Research Solutions GmbH, Muenster, Germany.

Marta Bertolini (M)

Monasterium Laboratory, Skin and Hair Research Solutions GmbH, Muenster, Germany. m.bertolini@monasteriumlab.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH